An Integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts

被引:120
作者
Cho, Sung-Yup [1 ]
Kang, Wonyoung [1 ]
Han, Jee Yun [1 ]
Min, Seoyeon [1 ]
Kang, Jinjoo [1 ]
Lee, Ahra [1 ]
Kwon, Jee Young [1 ,2 ]
Lee, Charles [1 ,2 ]
Park, Hansoo [1 ,2 ]
机构
[1] Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea
[2] Jackson Lab Genom Med, Farmington, CT 06032 USA
基金
新加坡国家研究基金会;
关键词
cancer drug development; cancer genomics; patient-derived xenografts; precision medicine; BREAST-CANCER; TUMOR XENOGRAFTS; MOLECULAR CHARACTERIZATION; ORTHOTOPIC XENOGRAFTS; PANCREATIC-CANCER; NAB-PACLITAXEL; LUNG CANCERS; MOUSE MODELS; IN-VITRO; GLIOBLASTOMA;
D O I
10.14348/molcells.2016.2350
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cancer is a heterogeneous disease caused by diverse genomic alterations in oncogenes and tumor suppressor genes. Despite recent advances in high-throughput sequencing technologies and development of targeted therapies, novel cancer drug development is limited due to the high attrition rate from clinical studies. Patient-derived xenografts (PDX), which are established by the transfer of patient tumors into immunodeficient mice, serve as a platform for co-clinical trials by enabling the integration of clinical data, genomic profiles, and drug responsiveness data to determine precisely targeted therapies. PDX models retain many of the key characteristics of patients' tumors including histology, genomic signature, cellular heterogeneity, and drug responsiveness. These models can also be applied to the development of biomarkers for drug responsiveness and personalized drug selection. This review summarizes our current knowledge of this field, including methodologic aspects, applications in drug development, challenges and limitations, and utilization for precision cancer medicine.
引用
收藏
页码:77 / 86
页数:10
相关论文
共 74 条
[1]   Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rγ null mice generate a faster and more efficient disease compared to other NOD/scid-related strains [J].
Agliano, Alice ;
Martin-Padura, Ines ;
Mancuso, Patrizia ;
Marighetti, Paola ;
Rabascio, Cristina ;
Pruneri, Giancarlo ;
Shultz, Leonard D. ;
Bertolini, Francesco .
INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (09) :2222-2227
[2]   Examining the utility of patient-derived xenograft mouse models [J].
Aparicio, Samuel ;
Hidalgo, Manuel ;
Kung, Andrew L. .
NATURE REVIEWS CANCER, 2015, 15 (05) :311-316
[3]   Stromal interaction molecule 2 (STIM2) is frequently overexpressed in colorectal tumors and confers a tumor cell growth suppressor phenotype [J].
Aytes, Alvaro ;
Mollevi, David G. ;
Martinez-Iniesta, Maria ;
Nadal, Marga ;
Vidal, August ;
Morales, Albert ;
Salazar, Ramon ;
Capella, Gabriel ;
Villanueva, Alberto .
MOLECULAR CARCINOGENESIS, 2012, 51 (09) :746-753
[4]   Integrated genomic analyses of ovarian carcinoma [J].
Bell, D. ;
Berchuck, A. ;
Birrer, M. ;
Chien, J. ;
Cramer, D. W. ;
Dao, F. ;
Dhir, R. ;
DiSaia, P. ;
Gabra, H. ;
Glenn, P. ;
Godwin, A. K. ;
Gross, J. ;
Hartmann, L. ;
Huang, M. ;
Huntsman, D. G. ;
Iacocca, M. ;
Imielinski, M. ;
Kalloger, S. ;
Karlan, B. Y. ;
Levine, D. A. ;
Mills, G. B. ;
Morrison, C. ;
Mutch, D. ;
Olvera, N. ;
Orsulic, S. ;
Park, K. ;
Petrelli, N. ;
Rabeno, B. ;
Rader, J. S. ;
Sikic, B. I. ;
Smith-McCune, K. ;
Sood, A. K. ;
Bowtell, D. ;
Penny, R. ;
Testa, J. R. ;
Chang, K. ;
Dinh, H. H. ;
Drummond, J. A. ;
Fowler, G. ;
Gunaratne, P. ;
Hawes, A. C. ;
Kovar, C. L. ;
Lewis, L. R. ;
Morgan, M. B. ;
Newsham, I. F. ;
Santibanez, J. ;
Reid, J. G. ;
Trevino, L. R. ;
Wu, Y. -Q. ;
Wang, M. .
NATURE, 2011, 474 (7353) :609-615
[5]   Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment [J].
Bertolini, Giulia ;
Roz, Luca ;
Perego, Paola ;
Tortoreto, Monica ;
Fontanella, Enrico ;
Gatti, Laura ;
Pratesi, Graziella ;
Fabbri, Alessandra ;
Andriani, Francesca ;
Tinelli, Stella ;
Roz, Elena ;
Caserini, Roberto ;
Lo Vullo, Salvatore ;
Camerini, Tiziana ;
Mariani, Luigi ;
Delia, Domenico ;
Calabro, Elisa ;
Pastorino, Ugo ;
Sozzi, Gabriella .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (38) :16281-16286
[6]   A Molecularly Annotated Platform of Patient-Derived Xenografts ("Xenopatients") Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer [J].
Bertotti, Andrea ;
Migliardi, Giorgia ;
Galimi, Francesco ;
Sassi, Francesco ;
Torti, Davide ;
Isella, Claudio ;
Cora, Davide ;
Di Nicolantonio, Federica ;
Buscarino, Michela ;
Petti, Consalvo ;
Ribero, Dario ;
Russolillo, Nadia ;
Muratore, Andrea ;
Massucco, Paolo ;
Pisacane, Alberto ;
Molinaro, Luca ;
Valtorta, Emanuele ;
Sartore-Bianchi, Andrea ;
Risio, Mauro ;
Capussotti, Lorenzo ;
Gambacorta, Marcello ;
Siena, Salvatore ;
Medico, Enzo ;
Sapino, Anna ;
Marsoni, Silvia ;
Comoglio, Paolo M. ;
Bardelli, Alberto ;
Trusolino, Livio .
CANCER DISCOVERY, 2011, 1 (06) :508-523
[7]   Human Solid Tumor Xenografts in Immunodeficient Mice Are Vulnerable to Lymphomagenesis Associated with Epstein-Barr Virus [J].
Chen, Kui ;
Ahmed, Sharif ;
Adeyi, Oyedele ;
Dick, John E. ;
Ghanekar, Anand .
PLOS ONE, 2012, 7 (06)
[8]   Lessons from patient-derived xenografts for better in vitro modeling of human cancer [J].
Choi, Stephen Yiu Chuen ;
Lin, Dong ;
Gout, Peter W. ;
Collins, Colin C. ;
Xu, Yong ;
Wang, Yuzhuo .
ADVANCED DRUG DELIVERY REVIEWS, 2014, 79-80 :222-237
[9]   Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance [J].
Das Thakur, Meghna ;
Salangsang, Fernando ;
Landman, Allison S. ;
Sellers, William R. ;
Pryer, Nancy K. ;
Levesque, Mitchell P. ;
Dummer, Reinhard ;
McMahon, Martin ;
Stuart, Darrin D. .
NATURE, 2013, 494 (7436) :251-255
[10]   Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice [J].
de Groot, John F. ;
Fuller, Gregory ;
Kumar, Ashok J. ;
Piao, Yuji ;
Eterovic, Karina ;
Ji, Yongjie ;
Conrad, Charles A. .
NEURO-ONCOLOGY, 2010, 12 (03) :233-242